Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control (Q34670457)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control (English)

1 reference

Europe PubMed Central

3 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Chiao-Po Hsu

1

1 reference

Europe PubMed Central

3 August 2017

Pai-Feng Hsu

2

1 reference

Europe PubMed Central

3 August 2017

Ming-Yi Chung

3

1 reference

Europe PubMed Central

3 August 2017

Shing-Jong Lin

4

1 reference

Europe PubMed Central

3 August 2017

Tse-Min Lu

5

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

3 December 2014

1 reference

Europe PubMed Central

3 August 2017

Cardiovascular Diabetology

1 reference

Europe PubMed Central

3 August 2017

13

1 reference

Europe PubMed Central

3 August 2017

156

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/s12933-014-0156-1

0 references

ADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4262144

7 July 2018

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxid

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0156-1

21 January 2018

Dimethylarginines in patients with type 2 diabetes mellitus: relation with the glycaemic control

1 reference

https://pubmed.ncbi.nlm.nih.gov/25467091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and Identification of N,N- and N,N' -Dimethylarginine, Nε-Mono-, Di-, and Trimethyllysine, and Glucosylgalactosyl- and Galactosyl-δ-hydroxylysine from Human Urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25467091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25467091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25467091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble RAGE in type 2 diabetes: Association with oxidative stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/25467091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators

1 reference

https://pubmed.ncbi.nlm.nih.gov/25467091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12933-014-0156-1

1 reference

Europe PubMed Central

3 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34670457&oldid=1859510930"